Zibo Qixiang Tengda Chemical Past Earnings Performance
Past criteria checks 0/6
Zibo Qixiang Tengda Chemical's earnings have been declining at an average annual rate of -16.1%, while the Chemicals industry saw earnings growing at 8.5% annually. Revenues have been declining at an average rate of 2.2% per year.
Key information
-16.1%
Earnings growth rate
-17.9%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | -2.2% |
| Return on equity | -2.8% |
| Net Margin | -1.0% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Zibo Qixiang Tengda Chemical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 26,256 | -272 | 570 | 683 |
| 31 Dec 23 | 26,918 | -384 | 470 | 655 |
| 30 Sep 23 | 26,766 | -226 | 882 | 685 |
| 30 Jun 23 | 27,191 | -247 | 829 | 698 |
| 31 Mar 23 | 28,025 | -1 | 732 | 710 |
| 01 Jan 23 | 29,810 | 634 | 687 | 706 |
| 30 Sep 22 | 32,415 | 1,279 | 609 | 691 |
| 30 Jun 22 | 33,548 | 1,825 | 527 | 661 |
| 31 Mar 22 | 34,119 | 2,282 | 560 | 634 |
| 01 Jan 22 | 34,892 | 2,393 | 601 | 579 |
| 30 Sep 21 | 34,108 | 2,352 | 500 | 471 |
| 30 Jun 21 | 32,524 | 1,969 | 553 | 386 |
| 31 Mar 21 | 28,689 | 1,445 | 529 | 276 |
| 31 Dec 20 | 24,686 | 976 | 498 | 271 |
| 30 Sep 20 | 22,345 | 884 | 575 | 332 |
| 30 Jun 20 | 23,458 | 742 | 569 | 297 |
| 31 Mar 20 | 27,642 | 629 | 545 | 295 |
| 31 Dec 19 | 30,058 | 620 | 556 | 316 |
| 30 Sep 19 | 36,355 | 669 | 563 | 332 |
| 30 Jun 19 | 36,813 | 692 | 510 | 367 |
| 31 Mar 19 | 31,903 | 782 | 523 | 383 |
| 31 Dec 18 | 27,924 | 843 | 469 | 307 |
| 30 Sep 18 | 25,060 | 974 | 403 | 276 |
| 30 Jun 18 | 25,109 | 1,031 | 353 | 362 |
| 31 Mar 18 | 23,220 | 902 | 371 | 284 |
| 31 Dec 17 | 22,226 | 850 | 379 | 282 |
| 30 Sep 17 | 15,041 | 823 | 419 | 178 |
| 30 Jun 17 | 8,417 | 692 | 495 | 0 |
| 31 Mar 17 | 7,003 | 661 | 444 | 0 |
| 31 Dec 16 | 5,875 | 502 | 437 | 0 |
| 30 Sep 16 | 4,692 | 270 | 447 | 0 |
| 30 Jun 16 | 4,355 | 191 | 384 | 0 |
| 31 Mar 16 | 4,382 | 161 | 361 | 0 |
| 31 Dec 15 | 4,278 | 184 | 343 | 0 |
| 30 Sep 15 | 4,422 | 174 | 348 | 0 |
| 30 Jun 15 | 4,838 | 248 | 350 | 0 |
| 31 Mar 15 | 5,013 | 285 | 330 | 0 |
| 31 Dec 14 | 5,200 | 299 | 330 | 0 |
| 30 Sep 14 | 5,090 | 333 | 248 | 0 |
| 30 Jun 14 | 4,429 | 309 | 225 | 0 |
| 31 Mar 14 | 3,709 | 317 | 211 | 0 |
| 31 Dec 13 | 3,771 | 346 | 193 | 0 |
| 30 Sep 13 | 3,873 | 386 | 175 | 0 |
| 30 Jun 13 | 4,202 | 433 | 172 | 0 |
Quality Earnings: 002408 is currently unprofitable.
Growing Profit Margin: 002408 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 002408 is unprofitable, and losses have increased over the past 5 years at a rate of 16.1% per year.
Accelerating Growth: Unable to compare 002408's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 002408 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-20.1%).
Return on Equity
High ROE: 002408 has a negative Return on Equity (-2.84%), as it is currently unprofitable.